Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
Full name: Terapia SA
Legal Form: Public Limited Company
Operational Status: Operational
Number of Registration in the Trade Registry: J12/2038/2004
Incorporation Date: 2004
Medicines and pharmaceutical products, active substances for pharmaceutical industry.
Established in 1921, Terapia is the largest generic pharmaceutical company in Romania with strong brands and a consistent track record of growth. Terapia SA has a large product portfolio and a robust distribution network, including the largest generic sales force in the country. On 8 June 2006, Ranbaxy Laboratories Ltd. announced the completion of acquisition by Ranbaxy Netherlands BV of 96.7% of Terapia SA. After this acquisition, the company was liquidated, saw the establishment of a new company with theMore
EMIS Benchmark Score
|Net sales revenue|
|Total operating revenue|
|Operating profit (EBIT)|
|Net Profit (Loss) for the Period|
|Operating Profit (EBIT) Margin|
|Return on Sales (ROS)|
|Return on Equity (ROE)|
|Debt to Equity|
|Company Tear Sheet|
|NAICS Industry Classification||✓||✕|
|Share Price information||✓||✕|
|Subsidiaries and Affiliates||✓||✕|
|Key Financial Highlights||✓||✕|
|Financial Performance Charts||✓||✕|
|Latest M&A and ECM Deals||✓||✕|
|EMIS Credit Analytics|
|EMIS Benchmark Score||✓||✕|
- or -
EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.
If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.